Lataa...
Type I interferon antagonists in clinical development for lupus
INTRODUCTION: Systemic lupus erythematosus (SLE) is a severe chronic and incurable autoimmune disease. Treatment includes glucocorticoids and small molecule immunosuppressants which typically result in partial responses, and hence there is a great need for new therapies. The type I interferon (IFN)...
Tallennettuna:
| Julkaisussa: | Expert Opin Investig Drugs |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7924012/ https://ncbi.nlm.nih.gov/pubmed/32700979 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/13543784.2020.1797677 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|